VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 367 filers reported holding VANECK VECTORS ETF TR in Q3 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,027,923 | -52.0% | 38,199 | -46.3% | 0.03% | -50.9% |
| Q2 2023 | $2,141,358 | +6.5% | 71,118 | +14.4% | 0.06% | +1.8% |
| Q1 2023 | $2,010,717 | +22.9% | 62,155 | +8.9% | 0.06% | +12.0% |
| Q4 2022 | $1,636,173 | +127.6% | 57,089 | +91.5% | 0.05% | +100.0% |
| Q3 2022 | $719,000 | -5.6% | 29,818 | +7.1% | 0.02% | -3.8% |
| Q2 2022 | $762,000 | -53.1% | 27,842 | -34.3% | 0.03% | -45.8% |
| Q1 2022 | $1,626,000 | -5.5% | 42,376 | -21.1% | 0.05% | -4.0% |
| Q4 2021 | $1,721,000 | +15.1% | 53,733 | +5.9% | 0.05% | +4.2% |
| Q3 2021 | $1,495,000 | -47.7% | 50,732 | -39.7% | 0.05% | -46.7% |
| Q2 2021 | $2,858,000 | +10.3% | 84,100 | +5.5% | 0.09% | -6.2% |
| Q1 2021 | $2,590,000 | +151.7% | 79,693 | +178.9% | 0.10% | +134.1% |
| Q4 2020 | $1,029,000 | +1.3% | 28,575 | +10.2% | 0.04% | -14.6% |
| Q3 2020 | $1,016,000 | +111.2% | 25,939 | +97.9% | 0.05% | +84.6% |
| Q2 2020 | $481,000 | -65.2% | 13,108 | -78.1% | 0.03% | -71.1% |
| Q1 2020 | $1,381,000 | -35.5% | 59,936 | -18.0% | 0.09% | -20.4% |
| Q4 2019 | $2,140,000 | -0.5% | 73,085 | -13.2% | 0.11% | -14.4% |
| Q3 2019 | $2,151,000 | 0.0% | 84,181 | 0.0% | 0.13% | 0.0% |
| Q2 2019 | $2,151,000 | +15.1% | 84,181 | +1.0% | 0.13% | +0.8% |
| Q1 2019 | $1,868,000 | +1.8% | 83,317 | -4.2% | 0.13% | -18.1% |
| Q4 2018 | $1,835,000 | +7240.0% | 86,986 | +6126.6% | 0.16% | +7900.0% |
| Q3 2018 | $25,000 | -34.2% | 1,397 | -22.1% | 0.00% | -33.3% |
| Q2 2018 | $38,000 | -93.1% | 1,793 | -92.8% | 0.00% | -93.2% |
| Q1 2018 | $550,000 | -18.5% | 25,011 | -13.9% | 0.04% | -25.4% |
| Q4 2017 | $675,000 | -0.7% | 29,061 | -1.8% | 0.06% | -24.4% |
| Q3 2017 | $680,000 | -7.1% | 29,604 | -10.7% | 0.08% | -17.9% |
| Q2 2017 | $732,000 | +13.5% | 33,150 | +17.2% | 0.10% | +1.1% |
| Q1 2017 | $645,000 | +1.3% | 28,278 | +17.3% | 0.09% | -21.7% |
| Q3 2016 | $637,000 | -24.9% | 24,104 | -21.2% | 0.12% | -37.8% |
| Q2 2016 | $848,000 | – | 30,605 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |